- Report
- January 2022
- 200 Pages
Global
From €6614EUR$7,500USD£5,705GBP
- Report
- January 2022
- 60 Pages
Global
From €3484EUR$3,950USD£3,005GBP
- Report
- January 2022
- 60 Pages
Global
From €3484EUR$3,950USD£3,005GBP
- Clinical Trials
- September 2021
- 60 Pages
Global
From €1323EUR$1,500USD£1,141GBP
- Drug Pipelines
- September 2021
- 60 Pages
Global
From €1323EUR$1,500USD£1,141GBP
- Report
- August 2020
- 80 Pages
Global
From €2425EUR$2,750USD£2,092GBP
- Report
- August 2020
- 80 Pages
Global
From €2866EUR$3,250USD£2,472GBP
- Report
- August 2020
- 80 Pages
Global
From €2866EUR$3,250USD£2,472GBP
- Report
- September 2024
- 82 Pages
Japan
From €2624EUR$2,975USD£2,263GBP
€3087EUR$3,500USD£2,662GBP
- Report
- August 2024
- 80 Pages
Japan
From €2624EUR$2,975USD£2,263GBP
€3087EUR$3,500USD£2,662GBP
- Report
- May 2024
- 182 Pages
Global
From €3373EUR$3,825USD£2,910GBP
€3969EUR$4,500USD£3,423GBP
- Report
- April 2024
- 82 Pages
United States
From €2624EUR$2,975USD£2,263GBP
€3087EUR$3,500USD£2,662GBP
- Report
- February 2024
- 185 Pages
Global
From €3373EUR$3,825USD£2,910GBP
€3969EUR$4,500USD£3,423GBP
- Report
- February 2024
- 180 Pages
Global
From €3373EUR$3,825USD£2,910GBP
€3969EUR$4,500USD£3,423GBP
- Report
- February 2024
- 182 Pages
Global
From €3373EUR$3,825USD£2,910GBP
€3969EUR$4,500USD£3,423GBP
- Report
- February 2024
- 181 Pages
Global
From €3373EUR$3,825USD£2,910GBP
€3969EUR$4,500USD£3,423GBP
- Report
- October 2023
- 178 Pages
Global
From €3373EUR$3,825USD£2,910GBP
€3969EUR$4,500USD£3,423GBP
- Report
- September 2023
- 83 Pages
Israel
From €2624EUR$2,975USD£2,263GBP
€3087EUR$3,500USD£2,662GBP
- Report
- September 2023
- 90 Pages
Egypt
From €2624EUR$2,975USD£2,263GBP
€3087EUR$3,500USD£2,662GBP
- Report
- August 2023
- 75 Pages
Israel
From €2624EUR$2,975USD£2,263GBP
€3087EUR$3,500USD£2,662GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more